Terkko Navigator / Alimentary Pharmacology & Therapeutics

Impact of Epstein‐Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease

Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (AID)

HINT: a novel prognostic model for patients with hepatitis B virus‐related acute‐on‐chronic liver failure

Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testing

Editorial: surviving your genes—the role of PNPLA3 variation in end‐stage liver disease. Authors’ reply

Editorial: interferon‐free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia—Authors’ reply

Editorial: surviving your genes—the role of PNPLA3 variation in end‐stage liver disease

Editorial: STAT‐4 polymorphism ‐ a tool to personalise clinical practice in chronic HBV infection

Editorial: STAT‐4 polymorphism ‐ a tool to personalise clinical practice in chronic HBV infection. Authors’ reply

Editorial: interferon‐free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia

Issue Information

Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Anti‐TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif (AID)

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom

The role of multimodal treatment in Crohn′s disease patients with perianal fistula: a multicentre retrospective cohort study

Male gender, active smoking and previous intestinal resection are risk factors of post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment

A comparison of the risk of postoperative recurrence between African‐American and Caucasian patients with Crohn's disease

Quality of life in coeliac disease: item reduction, scale development and psychometric evaluation of the Coeliac Disease Assessment Questionnaire (CDAQ)

Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study

Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis

Combined diffusion tensor imaging and magnetic resonance spectroscopy to predict neurological outcome before transjugular intrahepatic portosystemic shunt

Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel

Liver fat scores predict liver disease mortality in the United States population

Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view

Review article: an analysis of safety profiles of the treatments for diarrhoea‐predominant irritable bowel syndrome

Review article: the relationship between obesity, bariatric surgery, and inflammatory bowel disease

Systematic review and meta‐analysis: conditioned pain modulation in patients with the irritable bowel syndrome

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study

Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non‐interferon‐based treatments

Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case‐control study

Real‐world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease

The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis

Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls

Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis

Letter: cohort study examining the association between proton pump inhibitors therapy and risk of hepatocellular carcinoma in Taiwan—authors’ reply

Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan

Editorial: anxiety and depression in inflammatory bowel disease

Editorial: paradoxical skin lesions during anti‐TNF treatment—an additional argument to consider new biologics as first‐line therapy in inflammatory bowel disease. Authors’ reply

Editorial: control of acid secretion

Editorial: paradoxical skin lesions during anti‐TNF treatment—an additional argument to consider new biologics as first line therapy in inflammatory bowel disease

Editorial: anxiety and depression in inflammatory bowel disease– authors’ reply

Issue Information

Review article: systemic treatment of hepatocellular carcinoma

Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients